<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2687-0940</journal-id><journal-title-group><journal-title>Challenges in modern medicine</journal-title></journal-title-group><issn pub-type="epub">2687-0940</issn></journal-meta><article-meta><article-id pub-id-type="publisher-id">65</article-id><article-categories><subj-group subj-group-type="heading"><subject>STOMATOLOGY</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Levels of several cytokines in serum and oral fluid in postmenopausal women with chronic generalized periodontitis and osteoporosis&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Levels of several cytokines in serum and oral fluid in postmenopausal women with chronic generalized periodontitis and osteoporosis&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Maylyan</surname><given-names>Edward A.</given-names></name><name xml:lang="en"><surname>Maylyan</surname><given-names>Edward A.</given-names></name></name-alternatives><email>eduard.mailyan@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Chaykovskaya</surname><given-names>Ilona V.</given-names></name><name xml:lang="en"><surname>Chaykovskaya</surname><given-names>Ilona V.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Soboleva</surname><given-names>Anna A.</given-names></name><name xml:lang="en"><surname>Soboleva</surname><given-names>Anna A.</given-names></name></name-alternatives><email>mea095@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Lesnichenko</surname><given-names>Denis A.</given-names></name><name xml:lang="en"><surname>Lesnichenko</surname><given-names>Denis A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kostetskaya</surname><given-names>Natalia I.</given-names></name><name xml:lang="en"><surname>Kostetskaya</surname><given-names>Natalia I.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="epub"><year>2021</year></pub-date><volume>44</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/journal-medicine/2021/1/79-91.pdf" /><abstract xml:lang="ru"><p>In 212 postmenopausal women with moderate chronic generalized periodontitis (MCGP), of which 73 women with normal bone mineral density, 71 with osteopenia, and 68 with osteoporosis (OP), was determined the serum concentration of interleukins (IL) -1&amp;beta;, -4, -6, -8, -10, tumor necrosis factor alpha &amp;ndash; TNF-&amp;alpha;, interferon gamma &amp;ndash; INF-&amp;gamma;, in the oral fluid &amp;ndash; levels of IL-1&amp;beta;, IL-6 and TNF-&amp;alpha;. In postmenopausal women with MCGP, it was found (p &amp;lt; 0,05) a decrease the level of IL-4 and an increase the concentrations of IL-1&amp;beta;, IL-6 and IL-8 in the blood serum, as well as an increase the secretion of IL-6 and TNF -&amp;alpha; in the oral fluid. In women with MCGP against the background of OP, a decrease IL-4 levels and an increase serum IL-1&amp;beta;, IL-6, IL-8, TNF-&amp;alpha;, and increase IL-6 and TNF-&amp;alpha; values in the oral fluid are recorded. The presence of MCGP and osteopenia is combined with an increase (p &amp;lt; 0,05) the content of IL-6 and IL-8 in the blood serum, IL-6 and TNF-&amp;alpha; in the oral fluid. Postmenopausal women with MCGP who do not have osteoporotic disorders are characterized (p &amp;lt; 0,05) by increased serum concentrations of IL-1&amp;beta; and IL-6, and IL-6 and TNF-&amp;alpha; in the oral fluid.</p></abstract><trans-abstract xml:lang="en"><p>In 212 postmenopausal women with moderate chronic generalized periodontitis (MCGP), of which 73 women with normal bone mineral density, 71 with osteopenia, and 68 with osteoporosis (OP), was determined the serum concentration of interleukins (IL) -1&amp;beta;, -4, -6, -8, -10, tumor necrosis factor alpha &amp;ndash; TNF-&amp;alpha;, interferon gamma &amp;ndash; INF-&amp;gamma;, in the oral fluid &amp;ndash; levels of IL-1&amp;beta;, IL-6 and TNF-&amp;alpha;. In postmenopausal women with MCGP, it was found (p &amp;lt; 0,05) a decrease the level of IL-4 and an increase the concentrations of IL-1&amp;beta;, IL-6 and IL-8 in the blood serum, as well as an increase the secretion of IL-6 and TNF -&amp;alpha; in the oral fluid. In women with MCGP against the background of OP, a decrease IL-4 levels and an increase serum IL-1&amp;beta;, IL-6, IL-8, TNF-&amp;alpha;, and increase IL-6 and TNF-&amp;alpha; values in the oral fluid are recorded. The presence of MCGP and osteopenia is combined with an increase (p &amp;lt; 0,05) the content of IL-6 and IL-8 in the blood serum, IL-6 and TNF-&amp;alpha; in the oral fluid. Postmenopausal women with MCGP who do not have osteoporotic disorders are characterized (p &amp;lt; 0,05) by increased serum concentrations of IL-1&amp;beta; and IL-6, and IL-6 and TNF-&amp;alpha; in the oral fluid.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Generalized periodontitis</kwd><kwd>postmenopausal osteoporosis</kwd><kwd>cytokines</kwd><kwd>blood serum</kwd><kwd>oral fluid</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Generalized periodontitis</kwd><kwd>postmenopausal osteoporosis</kwd><kwd>cytokines</kwd><kwd>blood serum</kwd><kwd>oral fluid</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Balitskaya O.Yu., Bondarenko Yu.I., Antonishin I.V., Gabor G.G. 2019. Assotsiatsiya mezhdu provospalitel&amp;#39;nymi tsitokinami i khronicheskim generalizovannym parodontitom u bol&amp;#39;nykh sakharnym diabetom 2 tipa [Associations between proinflammatory cytokines and chronic generalized periodontitis in patients with type 2 diabetes mellitus]. A. T. J., 4: 19&amp;ndash;24.</mixed-citation></ref><ref id="B2"><mixed-citation>Borisenko A.V., Kolenko Y.G., Timokhina T.O. 2019. Porushennja mіscevogo іmunіtetu ta citokіnovogo statusu u hvorih na generalіzovanij parodontit [Violation of local immunity and cytokine status in patients with generalized periodontitis]. Suchasna stomatologіja, 1: 34&amp;ndash;37.</mixed-citation></ref><ref id="B3"><mixed-citation>Gordeev A.V., Galushko E.A., Savushkina N.M., Lila A.M. 2018. Parodontit &amp;ndash; predshestvennik revmatoidnogo artrita? [Is periodontitis a harbinger of rheumatoid arthritis?]. Nauchnoprakticheskaja revmatologija, 56 (5): 613&amp;ndash;621. doi: 10.14412/1995-4484-2018-613-621.</mixed-citation></ref><ref id="B4"><mixed-citation>Ignatenko G.A., Maylyan E.A., Nemsadze I.G., Rumyantseva Z.S., Churilov A.V., Glazkov I.S., Mirovich E.D. 2020. Rol&amp;#39; tsitokinov v remodelirovanii kostnoy tkani v norme i patologii [The role of cytokines in bone remodeling in norm and pathology]. Tavricheskiy mediko-biologicheskiy vestnik, 1: 133&amp;ndash;139. doi: 10.21886/2219-8075-2020-11-2-6-18.</mixed-citation></ref><ref id="B5"><mixed-citation>Ignatenko G.A., Nemsadze I.G., Mirovich E.D., Churilov A.V., Maylyan E.A., Glazkov I.S., Rumyantceva Z.S. 2020. The role of cytokines in bone remodeling and the pathogenesis of postmenopausal osteoporosis [The role of cytokines in bone remodeling and the pathogenesis of postmenopausal osteoporosis]. Medicinskij vestnik Juga Rossii, 11 (2): 6&amp;ndash;18. doi: 10.21886/2219-8075-2020-11-2-6-18.</mixed-citation></ref><ref id="B6"><mixed-citation>Maylyan E.A. 2018. Urovni tsitokinov u zhenshchin postmenopauzal&amp;#39;nogo vozrasta v zavisimosti ot polimorfizmov genov IL-6, TNFSF11 i TNFRSF11B [Cytokine levels in postmenopausal women depending on IL-6, TNFSF11 and TNFRSF11B genes polymorphisms]. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Meditsina. Farmatsiya, 41 (2): 235&amp;ndash;244.</mixed-citation></ref><ref id="B7"><mixed-citation>Maylyan E.A., Reznichenko N.A., Ignatenko G.A. 2018. Syvorotochnye urovni tsitokinov pri postmenopauzal&amp;#39;nom osteoporoze [Cytokines serum levels in postmenopausal osteoporosis]. Krymskiy zhurnal eksperimental&amp;#39;noy i klinicheskoy meditsiny, 1: 36&amp;ndash;42.</mixed-citation></ref><ref id="B8"><mixed-citation>Nazarova N.Sh., Rakhmanova N.R. 2020. Sostoyanie mestnogo immuniteta polosti rta pri khronicheskom generalizovannom paradontite [The state of local immunity of the oral cavity in chronic generalized periodontitis]. Dostizheniya nauki i obrazovaniya, 6 (60): 65&amp;ndash;70.</mixed-citation></ref><ref id="B9"><mixed-citation>Petrukhina N.B., Zorina O.A., Shikh E.V., Kartysheva E.V., Kudryavtsev A.V. 2019. Prognosticheskaya model&amp;#39; dlya otsenki khronicheskogo generalizovannogo parodontita u patsientov s metabolicheskim sindromom [A prognostic model for the prediction of generalized chronic periodontitis in patients with metabolic syndrome]. Vestnik RGMU, 2: 48&amp;ndash;52. doi: 10.24075/VRGMU.2019.026.</mixed-citation></ref><ref id="B10"><mixed-citation>Povoroznyuk V.V., Reznichenko N.A., Maylyan E.A. 2013. Immunologicheskie aspekty postmenopauzal&amp;#39;nogo osteoporoza [Immunological aspects of postmenopausal osteoporosis]. Bol&amp;#39;. Sustavy. Pozvonochnik, 3: 21&amp;ndash;26.</mixed-citation></ref><ref id="B11"><mixed-citation>Povoroznyuk V.V., Reznichenko N.A., Maylyan E.A. 2013. Rol&amp;#39; immunnyh faktorov v patogeneze postmenopauzal&amp;#39;nogo osteoporoza [Role of immune factors in the pathogenesis of postmenopausal osteoporosis]. Problemi osteologіi, 3: 3&amp;ndash;7.</mixed-citation></ref><ref id="B12"><mixed-citation>Chaykovskaya I.V., Prilutskiy A.S., Maylyan E.A. 2005. Metodika podgotovki prob slyuny dlya opredeleniya faktora nekroza opukholi al&amp;#39;fa i interleykina-8 [Preparation of saliva samples for the determination of tumor necrosis factor alpha and interleukin-8]. Іmunologіya ta alergologіya, 3: 48&amp;ndash;51.</mixed-citation></ref><ref id="B13"><mixed-citation>Shaymardanov T.N., Gerasimova L.P., Chemikosova T.S., Kamilov F.Kh. 2017. Otsenka urovnya provospalitel&amp;#39;nykh tsitokinov u patsientov s khronicheskim parodontitom v zavisimosti ot mineral&amp;#39;noy plotnosti kosti pered dental&amp;#39;noy implantatsiey [Evaluation of proinflammatory cytokines in patients with chronic periodontitis, depending on the mineral density of bone prior to dental implants]. Sovremennye problemy nauki i obrazovaniya, 1: 65.</mixed-citation></ref><ref id="B14"><mixed-citation>Yudina N.A., Iryshkova O.V., Lunev M.A., Uspenskaya M.N., Blekanova V.A. 2012. Stepen&amp;#39; i kharakter immunometabolicheskikh narusheniy u bol&amp;#39;nykh s vospalitel&amp;#39;nymi zabolevaniyami parodonta i ostrym odontogennym osteomielitom chelyustno-litsevoy oblasti [Degree and nature of immunometabolic disturbances at patients with inflammatory diseases parodontal and the acute dontogenous osteomyelitis of maxillofacial area]. Fundamental&amp;#39;nye issledovaniya, 5 (ch. 2): 397&amp;ndash;400.</mixed-citation></ref><ref id="B15"><mixed-citation>Acharya A.B., Thakur S., Muddapur M.V., Kulkarni R.D. 2016. Tumor necrosis factor-&amp;alpha;, interleukin-4 and -6 in the serum of health, chronic periodontitis, and type 2 diabetes mellitus. J. Indian. Soc. Periodontol., 20: 509&amp;ndash;513. doi: 10.4103/0972-124X.201694.</mixed-citation></ref><ref id="B16"><mixed-citation>Anie M.P., Dhayanand J.V., Ponnudurai S.G. 2012. Role of Interleukin-8 in Periodontal Disease. International Journal of Clinical Dental Science, 3: 32&amp;ndash;38.</mixed-citation></ref><ref id="B17"><mixed-citation>Baelum V., Lopez R. 2013. Periodontal disease epidemiology &amp;ndash; learned and unlearned? Periodontol 2000, 62 (1): 37&amp;ndash;58. doi: 10.1111/j.1600-0757.2012.00449.x.</mixed-citation></ref><ref id="B18"><mixed-citation>Batool H., Nadeem A., Kashif M., Shahzad F., Tahir R., Afzal N. 2018. Salivary Levels of IL-6 and IL-17 Could Be an Indicator of Disease Severity in Patients with Calculus Associated Chronic Periodontitis. BioMed research international, 8531961. doi: 10.1155/2018/8531961.</mixed-citation></ref><ref id="B19"><mixed-citation>Bose A., Shetty S., Ajila V. 2013. Molecular biology of host microbial interaction in periodontal disease. LAP LAMBERT Academic Publishing, 160.</mixed-citation></ref><ref id="B20"><mixed-citation>Engebretson S.P., Grbic J.T., Singer R., Lamster I.B. 2002. GCF IL-1beta profiles in periodontal disease. J. Clin. Periodontol., 29: 48&amp;ndash;53. doi: 10.1034/j.1600-051x.2002.290108.x.</mixed-citation></ref><ref id="B21"><mixed-citation>Faizuddin M., Bharathi S.H., Rohini N.V. 2003. Estimation of interleukin-1beta levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J. Periodontal. Res., 38: 111&amp;ndash;114. doi: 10.1034/j.1600-0765.2003.01649.x.</mixed-citation></ref><ref id="B22"><mixed-citation>Kusuhara M., Isoda K., Ohsuzu F. 2006. Interleukin-1 and occlusive arterial diseases. Cardiovasc. Hematol. Agents Med. Chem, 4: 229&amp;ndash;235. doi: 10.2174/187152506777698335.</mixed-citation></ref><ref id="B23"><mixed-citation>Liu H., Luo T., Tan J., Li M., Guo J. 2017. Osteoimmunology&amp;rsquo; Offers New Perspectives for the Treatment of Pathological Bone Loss. Curr. Pharm. Des., 23 (41): 6272&amp;ndash;6278. doi: 10.2174/1381612823666170511124459.</mixed-citation></ref><ref id="B24"><mixed-citation>Madureira D.F., Lucas De Abreu Lima I., Costa G.C., Lages E., Martins,C.C., Aparecida Da Silva T. 2018. Tumor Necrosis Factor-alpha in Gingival Crevicular Fluid as a Diagnostic Marker for Periodontal Diseases: A Systematic Review. The journal of evidence-based dental practice, 18 (4): 315&amp;ndash;331. doi: 10.1016/j.jebdp.2018.04.001.</mixed-citation></ref><ref id="B25"><mixed-citation>Pan W., Wang Q., Chen Q. 2019. The cytokine network involved in the host immune response to periodontitis. Int. J. Oral. Sci., 11 (30). doi: 10.1038/s41368-019-0064-z.</mixed-citation></ref><ref id="B26"><mixed-citation>Preshaw P.M. 2018. Periodontal disease pathogenesis. In: Takei H.H., Klokkevold P.R., Carranza F.A., editors. Carranza&amp;rsquo;s Clinical Periodontology. 13th ed. Philadelphia, Elsevier Saunders: 89&amp;ndash;111.</mixed-citation></ref><ref id="B27"><mixed-citation>Rangbulla V., Nirola A., Gupta M., Batra P., Gupta M. 2017. Salivary IgA, interleukin-1beta and MMP-8 as salivary biomarkers in chronic periodontitis patients. Chin. J. Dent. Res., 20: 43&amp;ndash;51. doi: 10.3290/j.cjdr.a37741.</mixed-citation></ref><ref id="B28"><mixed-citation>Reynolds I., Duane B. 2018. Periodontal disease has an impact on patients&amp;rsquo; quality of life. Evidence-Based Dentistry, 19 (1): 14&amp;ndash;15. doi: 10.1038/sj.ebd.6401287.</mixed-citation></ref><ref id="B29"><mixed-citation>Stadler A.F., Angst P.D., Arce R.M., Gomes S.C., Oppermann R.V., Susin C. 2016. Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: a meta-analysis. J. Clin. Periodontol., 43 (9): 727&amp;ndash;745. doi: 10.1111/jcpe.12557.</mixed-citation></ref><ref id="B30"><mixed-citation>Straka M., Straka-Trapezanlidis М., Deglovic J., Varga J. 2015. Periodontitis and osteoporosis. Neuro endocrinology letters, 36 (5): 401&amp;ndash;406.</mixed-citation></ref><ref id="B31"><mixed-citation>Sunkavalli A. 2012. The role of cytokines in periodontal diagnosis. LAP LAMBERT Academic Publishing, 97.</mixed-citation></ref><ref id="B32"><mixed-citation>Surlin P., Foia L., Solomon S., Popescu D.M., Gheorghe D.N., Camen A., Martu M.A., Rauten A.M., Olteanu M., Pitru A., Toma V., Popa S., Boldeanu M.N., Martu S., Rogoveanu I. 2020. Cytokines&amp;rsquo; Involvement in Periodontal Changes. doi: 10.5772/intechopen.89999.</mixed-citation></ref><ref id="B33"><mixed-citation>Tadjoedin F.M. The correlation between age and periodontal diseases. Journal of International Dental and Medical Research, 10 (2): 327&amp;ndash;332.</mixed-citation></ref><ref id="B34"><mixed-citation>Wang C.J., McCauley L.K. 2016. Osteoporosis and periodontitis. Current osteoporosis reports, 14 (6): 284&amp;ndash;291. doi: 10.1007/s11914-016-0330-3.</mixed-citation></ref><ref id="B35"><mixed-citation>Wu Q., Zhou X., Huang D., Yingchen J., Kang F. 2017. IL-6 enhances osteocytemediated osteoclastogenesis by promoting JAK2 and RANKL activity in vitro. Cell. Physiol. Biochem., 41: 1360&amp;ndash;1369. doi: 10.1159/000465455.</mixed-citation></ref><ref id="B36"><mixed-citation>Xu C., Cw Yi M., Nb Cheung M., Dou D., Dou Y.-D., Ty Loo W. 2020. Cytokines and Inflammatory Mediators for Monitoring the Status of Periodontitis. J. Dent. Oral. Biol., 5 (1): 1157.</mixed-citation></ref></ref-list></back></article>